Cargando…
Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ
General inflammatory diseases include skin inflammation, rheumatoid arthritis, inflammatory bowel diseases, sepsis, arteriosclerosis, and asthma. Although these diseases have been extensively studied, most of them are still difficult to treat. Meanwhile, NF-κB is a transcription factor promoting the...
Autores principales: | Ma, Jun, Zhang, Yuyang, Sugai, Takeshi, Kubota, Tetsuo, Keino, Hiroshi, El-Salhy, Magdy, Ozaki, Michitaka, Umezawa, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466912/ https://www.ncbi.nlm.nih.gov/pubmed/34571920 http://dx.doi.org/10.3390/cells10092271 |
Ejemplares similares
-
Anticancer Activity of Novel NF-κB Inhibitor DHMEQ by Intraperitoneal Administration
por: Umezawa, Kazuo, et al.
Publicado: (2020) -
Inhibition of Canonical NF-κB Nuclear Localization by (−)-DHMEQ via Impairment of DNA Binding
por: Horie, Kana, et al.
Publicado: (2015) -
The designed NF-κB inhibitor, DHMEQ, inhibits KISS1R-mediated invasion and increases drug-sensitivity in mouse plasmacytoma SP2/0 cells
por: Lin, Yinzhi, et al.
Publicado: (2021) -
Inhibition of MLCK‑mediated migration and invasion in human endometriosis stromal cells by NF‑κB inhibitor DHMEQ
por: Lin, Yinzhi, et al.
Publicado: (2023) -
Anti-inflammatory effects of novel AP-1 and NF-κB inhibitors in dextran-sulfate-sodium-induced colitis in rats
por: EL-SALHY, MAGDY, et al.
Publicado: (2016)